OrbiMed Advisors LLC's Form 4 filing
Damora Therapeutics, Inc. (DMRA) · filed Apr 7, 2023
- Accession no.
- 0000947871-23-000438
- Filed
- Apr 7, 2023, 4:42 PM ET
- Trade date
- Apr 5-6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $222.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | Common Stock | SSaleDisposed | −4,687 | $2.18 | −$10,217.66 | 187,100 | Indirect | |
| Apr 5, 2023 | Common Stock | SSaleDisposed | −25,220 | $2.18 | −$54,979.6 | 1,006,591 | Indirect | |
| Apr 5, 2023 | Common Stock | SSaleDisposed | −63,058 | $2.18 | −$137,466.44 | 2,516,599 | Indirect | |
| Apr 6, 2023 | Common Stock | SSaleDisposed | −487 | $2.00 | −$974 | 186,613 | Indirect | |
| Apr 6, 2023 | Common Stock | SSaleDisposed | −2,620 | $2.00 | −$5,240 | 1,003,971 | Indirect | |
| Apr 6, 2023 | Common Stock | SSaleDisposed | −6,558 | $2.00 | −$13,116 | 2,510,041 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.